Home Applications 761060 Application 761060
Type BLA
Sponsor WYETH PHARMS INC Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761060 Mylotarg gemtuzumab ozogamicin 351(a) Rx 2026-07-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 MYLOTARG GEMTUZUMAB OZOGAMICIN VIAL;SINGLE-DOSE 4.5MG No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Mylotarg GEMTUZUMAB OZOGAMICIN Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 32fd2bb2-1cfa-4250-feb8-d7956c794e05 2025-12-19 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761060 ndc (product): 0008-4510
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 8 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0008-4510 Mylotarg gemtuzumab ozogamicin Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. BLA Current 0008-4510 Mylotarg gemtuzumab ozogamicin Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. BLA Current 0008-4510 Mylotarg gemtuzumab ozogamicin Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. BLA Current 0008-4510 Mylotarg gemtuzumab ozogamicin Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. BLA Current 0008-4510 Mylotarg gemtuzumab ozogamicin Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. BLA Current 0008-4510 Mylotarg gemtuzumab ozogamicin Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. BLA Current 0008-4510 Mylotarg gemtuzumab ozogamicin Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. BLA Current 0008-4510 Mylotarg gemtuzumab ozogamicin Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. BLA Current
Documents# Document, Submission type, Date table Document Submission type Date 63586 SUPPL 2020-06-17 63575 SUPPL 2020-06-16 61990 SUPPL 2020-02-28 61989 SUPPL 2020-02-28 54476 ORIG 2018-06-08 54475 ORIG 2018-06-08 53663 SUPPL 2018-04-12 53657 SUPPL 2018-04-12 49679 ORIG 2017-09-06 49678 ORIG 2017-09-06 49653 ORIG 2017-09-01